Pulmonologist Intervention Beneficial for Undiagnosed Asthma, COPD
By Elana Gotkine HealthDay Reporter
TUESDAY, May 21, 2024 -- For adults with undiagnosed asthma and chronic obstructive pulmonary disease (COPD), receipt of pulmonologist-directed treatment is associated with less subsequent health care utilization for respiratory illness than usual care, according to a study published online May 19 in the New England Journal of Medicine to coincide with the American Thoracic Society 2024 International Conference, held from May 17 to 22 in San Diego.
Shawn D. Aaron, M.D., from the University of Ottawa in Canada, and colleagues identified adults in the community with respiratory symptoms without diagnosed lung disease. Participants who were found to have undiagnosed COPD or asthma on spirometry were assigned to receive the intervention or usual care by their primary care physician (253 and 255, respectively).
The researchers found that the annualized rate of a primary-outcome event was lower in the intervention versus the usual-care group (0.53 versus 1.12 events per person-year; incidence rate ratio, 0.48). At 12 months, the St. George Respiratory Questionnaire score was 10.2 and 6.8 points lower than the baseline score in the intervention and usual-care groups, respectively, and the COPD Assessment Test score was 3.8 and 2.6 points lower than baseline, respectively. The forced expiratory volume in one second increased by 119 and 22 mL in the intervention and usual-care groups, respectively. The trial groups had a similar incidence of adverse events.
"Although the results favored a pulmonologist-based intervention, the findings in the usual-care group suggest that management of previously undiagnosed asthma or COPD by a primary care practitioner may also be associated with positive changes in a patient's health status," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2024
Read this next
Antibiotic Exposure Before Age 2 May Increase Risk for Chronic Pediatric Conditions
WEDNESDAY, April 30, 2025 -- Children receiving multiple antibiotic courses between birth and age 2 years may have a higher risk for some chronic conditions, according to a study...
School-Based Asthma Therapy Boosts Asthma Control, Cuts Acute Health Care Use
THURSDAY, April 24, 2025 -- School-based asthma therapy (SBAT) can help improve children’s asthma control and decrease acute health care utilization, according to a study...
Midafternoon Dosing Improves Lung Function in Atopic Asthma
FRIDAY, April 18, 2025 -- Midafternoon dosing with beclomethasone dipropionate is associated with better clinical outcomes in mild-to-moderate atopic asthma, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.